Kim HS, Noh G. Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex.
Clin Case Rep 2023;
11:e6885. [PMID:
36698523 PMCID:
PMC9860130 DOI:
10.1002/ccr3.6885]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 12/15/2022] [Accepted: 01/03/2023] [Indexed: 01/22/2023] Open
Abstract
Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen-specific antinociceptive effect in the treatment of histamine-mediated pain.
Collapse